// App-Quantinova.ai

AB1438 (2022) : CARDIOVASCULAR RISK STRATIFICATION FOR TOFACITINIB PATIENTS IN A LARGE TEACHING HOSPITAL

Researchers

Presenter

  • A. Khatri

Principal Investigators

  • K. Tsoi

  • A. Rutherford

Medical Centers

  • St George Hospital, Haematology, London, United Kingdom

  • King's College Hospital, Biochemistry, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

Disease

  • Chronic kidney disease

  • Hypertension

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved